Researchers at the University of Florida College of Medicine say mRNA technology could "educate" the immune system to identify and attack cancer anywhere in the body. A promising proof-of-concept study using mice was published in Nature Biomedical Engineering.
Ritesh Kalra, MD, allegedly wrote 31,000 opioid prescriptions between 2019 and 2025, many of which were illegitimate. He is accused of inappropriately touching patients in exchange for oxycodone scripts as part of a five-count criminal indictment.
A problem with the B/V filters on SunMed adult resuscitators can cause the devices to malfunction. Due to the high safety risk this poses to patients, the FDA has assigned this recall its most serious designation.
Inmates in Illinois, Kentucky, Oregon, Utah and Vermont will be granted access to patient care services, including behavioral health and drug abuse interventions.
A former employee at Nuance Communications, a Microsoft subsidiary, stands accused of taking patient data from Geisinger Health system shortly after their termination.
Tracking private equity acquisitions can be challenging, but that didn't stop researchers from exploring the last decade of activity in cardiology. "It will be critical to monitor the effects on procedural utilization, quality and outcomes for patients with CVD,” the group wrote.
The failing health system allegedly hired intelligence firms that put a tracking device on a car, accessed a personal smartphone to find lurid information on an executive and attempted to frame a politician for bribery.
Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.
Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies.
The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services.
